Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The importance of myelodysplastic syndrome diagnosis

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.02.11
Views: 5234

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria

Dr Reinhard Stauder talks about the issue of misdiagnosis of elderly patients with myelodysplastic syndrome (MDS). If not treated correctly, 30% of patients with MDS will progress to acute myeloid leukaemia. Dr Struder discusses what clinicians can do to ensure they identify MDS and talks about information he is presenting at ASH 2010 based on a registry of patients with MDS. This registry, which monitors patient quality of life based on the EQ5D (European Quality of life 5 Dimensions) system, has shown how quality of life varies with factors such as age, sex and nationality. Dr Strauder considers why these differences occur and explains how this information will help clinicians treat MDS patients.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation